세계의 카프노그래피 장비 시장 : 제품별, 기술별, 용도별, 최종사용자별, 지역별 - 예측(-2029년)

The global Capnography Equipment market is projected to reach USD 458.8 million by 2029 from USD 374.2 million in 2024, growing at a CAGR of 4.2% during the forecast period. Growth factors include the high incidence of chronic respiratory diseases such as asthma, COPD, and sleep apnea are significantly driving the market for capnography equipment. An upsurge in home healthcare would require non-invasive monitoring solutions, thus boost the growth of this market. Improvements in technology especially about miniaturization, reduced profile, and wireless connectivity would ensure that capnography equipment is portable and user-friendly.

"Capnography accessories & disposables to register largest market share in 2022-2029."

The largest share in capnography equipment consists of capnography accessories & disposables. Capnography accessories and disposables are also some of the necessary parts of the proper working of capnography equipment. These include disposable sampling lines, filters, and connectors, which are very necessary to maintain hygiene levels and prevent cross-contamination. Calibration gases are also needed to ensure the accuracy of measurements of capnography. Other devices would include power cords, wall mounts, and carrying cases that increase the convenience and portability of capnography devices.

"Hospitals segment held the largest share of capnography equipment market in 2023, by End-user."

Based on the end-user, the capnography equipment market is segmented into hospitals. ambulatory surgery centers & home care and other end users. In the year 2023, the global capnography equipment market was dominated by hospitals. The use of capnography equipment is extremely prevalent in critical care areas, such as ICUs, operating rooms, emergency departments, and respiratory care units of hospitals. Such hospitals form the biggest market in the capnography equipment market because of this widespread usage. The growth of surgeries, critical care procedures, and respiratory illnesses has further led to a growing demand for capnography devices. In addition, the increased practice of monitoring patients for early respiratory complications detection along with the development of acute care has worked in favor of the integration of capnography in the clinical settings of hospitals.

"Asia Pacific to register highest growth rate in the market during the forecast period."

The Asia-Pacific region is projected to exhibit the highest CAGR in the capnography equipment market. This growth is primarily driven by factors such as increasing healthcare expenditure, rising prevalence of respiratory diseases, growing geriatric population, and increasing awareness about the benefits of early detection and treatment of respiratory disorders. Additionally, the expanding healthcare infrastructure and increasing adoption of advanced medical technologies in countries like India and China are further contributing to the growth of the capnography equipment market in this region.

A number of drivers were responsible for the upswing, including:

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier1- 40%, Tier2- 30%, and Tier 3- 30%
• By Designation: C-level-- 55%, Director-level-27%, and Others-18%
• By Region: North America-35%, Europe-32%, Asia Pacific-25%, Latin America-6% , Middle East & Africa-2%

Prominent players in this market are Becton, Dickinson and company (US), Medtronic (US), Koninklijke Philips N.V.(Netherlands), GE Healthcare (US), Dragerwerk AG (Germany), Nihon Kohden (Japan), Zoll Medical (US), Edan Instruments Inc (China), Hamilton Medical (Switzerland ), Masimo Corporation (US), Mindray (China), among others.

Research Coverage

Capnography equipment market is segmented by product, technology, application, end-user, and region. Factors determining market growth are driving forces, restrains, opportunities, and challenges, as well as those offering opportunities and challenges for stakeholders. Further examining the competitive landscape among the top players, the report does this. In doing so, it further segments the market into micro-markets for analyzing growth trends, prospects, and contribution to the overall market. It outlines the future revenue growth across the different market segments in five of the major regions.

Key Benefits of Buying the Report:

The report would be useful for new market entrants in the capnography equipment market as it gives detailed information about the market. This helps to get a good understanding of any investment opportunities. The report provides in-depth insight into key and smaller players which helps in doing strong risk assessment for investment decisions. The report segments the market precisely by both end-users and by regions to gain focused insights in specific market segments. Furthermore, it outlines the critical trends, challenges, growth drivers, and opportunities to facilitate strategic decision-making through well-rounded analysis.

The report provides the insights on the following pointers:

Analysis of the key drivers, restraints, opportunities, and challenges influencing the rise of the capnography equipment market The majority of the capnography equipment market is driven by the increase in chronic respiratory diseases such as asthma, COPD, and sleep apnea. There is an increasing demand for non-invasive monitoring solutions, especially in home care environments. Advancements in technology also involve miniaturization and wireless connectivity that enable smaller and user-friendly size capnography devices to be utilized.

Product Development/Innovation: The report showcases emerging technologies in the domain, ongoing R&D activities, and recent product and service launches in the market for capnography equipment.

Market Development: It has elaborated about the new product development and unexplored markets, latest developments, and investment in the capnography equipment market.

Market Diversification: Detailed insight into new product launches, unexplored markets, recent developments, and investments made in the capnography equipment market.

Competitive Assessment: Detailed assessment of market share, service offerings leading strategies of key players such as Becton, Dickinson and company (US), Medtronic (US), Koninklijke Philips N.V.(Netherlands), GE Healthcare (US), Dragerwerk AG (Germany), among others.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 SEGMENTS AND REGIONS CONSIDERED
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS
• 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key secondary sources
    • 2.1.1.2 Objectives of secondary research
    • 2.1.1.3 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key primary sources
    • 2.1.2.2 Objectives of primary research
    • 2.1.2.3 Key industry insights
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.1.1 Company revenue estimation approach
    • 2.2.1.2 Customer-based market estimation
  • 2.2.2 TOP-DOWN APPROACH
    • 2.2.2.1 Primary interviews
• 2.3 DATA TRIANGULATION
• 2.4 MARKET SHARE ASSESSMENT
• 2.5 STUDY ASSUMPTIONS
• 2.6 GROWTH RATE ASSUMPTIONS/MARKET FORECASTING METHODOLOGY
• 2.7 RESEARCH LIMITATIONS
• 2.8 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 CAPNOGRAPHY EQUIPMENT MARKET OVERVIEW
• 4.2 CAPNOGRAPHY EQUIPMENT MARKET, BY REGION, 2024 VS. 2029 (USD MILLION)
• 4.3 CAPNOGRAPHY EQUIPMENT MARKET, BY END USER AND COUNTRY, 2024 (USD MILLION)
• 4.4 GEOGRAPHIC SNAPSHOT OF CAPNOGRAPHY EQUIPMENT MARKET

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
  • 5.1.1 DRIVERS
    • 5.1.1.1 Increasing prevalence of respiratory diseases
    • 5.1.1.2 Clinical benefits of capnography over pulse oximetry
    • 5.1.1.3 Rising number of surgeries and target diseases requiring CO2 monitoring
  • 5.1.2 RESTRAINTS
    • 5.1.2.1 Complex regulatory framework for approval of capnography equipment
  • 5.1.3 OPPORTUNITIES
    • 5.1.3.1 Increased availability of clinical research evidence
    • 5.1.3.2 Growth opportunities for healthcare industry in emerging economies
  • 5.1.4 CHALLENGES
    • 5.1.4.1 Lack of skilled technicians and specialized training for operating capnometers
• 5.2 INDUSTRY TRENDS
  • 5.2.1 ADVANCEMENTS OF WEARABLE AND WIRELESS DEVICES
  • 5.2.2 INTEGRATION WITH MULTIPARAMETER MONITORS
• 5.3 VALUE CHAIN ANALYSIS
• 5.4 PORTER'S FIVE FORCES ANALYSIS
  • 5.4.1 THREAT OF NEW ENTRANTS
  • 5.4.2 BARGAINING POWER OF SUPPLIERS
  • 5.4.3 BARGAINING POWER OF BUYERS
  • 5.4.4 THREAT OF SUBSTITUTES
  • 5.4.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.5 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.5.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.5.2 KEY BUYING CRITERIA
• 5.6 PATENT ANALYSIS
• 5.7 TRADE DATA ANALYSIS
  • 5.7.1 IMPORT DATA FOR HS CODE 9018
  • 5.7.2 EXPORT DATA FOR HS CODE 9018
• 5.8 KEY CONFERENCES & EVENTS, 2024-2025
• 5.9 UNMET NEEDS AND KEY PAIN POINTS
• 5.10 ECOSYSTEM ANALYSIS
• 5.11 SUPPLY CHAIN ANALYSIS
  • 5.11.1 PROMINENT COMPANIES
  • 5.11.2 SMALL AND MEDIUM-SIZED ENTERPRISES
  • 5.11.3 END USERS
• 5.12 IMPACT OF AI/GEN AI ON CAPNOGRAPHY EQUIPMENT MARKET
• 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
• 5.14 TECHNOLOGY ANALYSIS
  • 5.14.1 KEY TECHNOLOGIES
    • 5.14.1.1 Mainstream capnography
    • 5.14.1.2 Side-stream capnography
    • 5.14.1.3 Waveform capnography
  • 5.14.2 COMPLEMENTARY TECHNOLOGIES
    • 5.14.2.1 Pulse oximetry
    • 5.14.2.2 Ventilators
  • 5.14.3 ADJACENT TECHNOLOGIES
    • 5.14.3.1 Microrotor technology
• 5.15 REGULATORY LANDSCAPE ANALYSIS
  • 5.15.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.15.2 REGULATORY FRAMEWORK
    • 5.15.2.1 North America
      • 5.15.2.1.1 US
    • 5.15.2.2 Europe
    • 5.15.2.3 Asia Pacific
      • 5.15.2.3.1 Japan
      • 5.15.2.3.2 India
      • 5.15.2.3.3 China
• 5.16 REIMBURSEMENT SCENARIO ANALYSIS
  • 5.16.1 REIMBURSEMENT CODES FOR CAPNOGRAPHY PROCEDURES
  • 5.16.2 REIMBURSEMENT LANDSCAPE FOR CAPNOGRAPHY EQUIPMENT, BY REGION
• 5.17 INVESTMENT & FUNDING SCENARIO
• 5.18 PRICING ANALYSIS
  • 5.18.1 INDICATIVE SELLING PRICE OF CAPNOGRAPHY EQUIPMENT, BY REGION
  • 5.18.2 AVERAGE SELLING PRICE FOR TOP THREE APPLICATIONS, BY KEY PLAYER, 2023

6 CAPNOGRAPHY EQUIPMENT MARKET, BY PRODUCT

• 6.1 INTRODUCTION
• 6.2 EQUIPMENT
  • 6.2.1 MULTIPARAMETER CAPNOMETERS
    • 6.2.1.1 Handheld multiparameter capnometers
      • 6.2.1.1.1 Improved patient safety, portability, and inbuilt audible and visual alarm to aid adoption
    • 6.2.1.2 Conventional multiparameter capnometers
      • 6.2.1.2.1 Increasing number of complex surgeries involving anesthesia to support segment growth
  • 6.2.2 STANDALONE CAPNOMETERS
    • 6.2.2.1 Handheld standalone capnometers
      • 6.2.2.1.1 Increasing number of emergency care visits and complex surgeries to propel segment growth
    • 6.2.2.2 Conventional standalone capnometers
      • 6.2.2.2.1 Easy portability and use in critical care settings to boost segment growth
• 6.3 SOFTWARE
  • 6.3.1 BETTER CLINICAL DECISION-MAKING AND PATIENT MANAGEMENT TO FUEL MARKET GROWTH
• 6.4 CAPNOGRAPHY ACCESSORIES & DISPOSABLES
  • 6.4.1 FAVORABLE REIMBURSEMENT SCENARIO TO SUPPORT MARKET GROWTH

7 CAPNOGRAPHY EQUIPMENT MARKET, BY TECHNOLOGY

• 7.1 INTRODUCTION
• 7.2 MAINSTREAM CAPNOGRAPHY
  • 7.2.1 HIGH ACCURACY, FAST RESPONSE TIME, AND IMPROVED SUITABILITY FOR NEONATES TO AID MARKET GROWTH
• 7.3 SIDE-STREAM CAPNOGRAPHY
  • 7.3.1 RELIABLE MEASUREMENT OF END-TIDAL CO2 LEVELS TO PROPEL ADOPTION IN CLINICAL SETTINGS
• 7.4 MICROSTREAM CAPNOGRAPHY
  • 7.4.1 LIMITATIONS IN BLACK-BODY INFRARED TECHNOLOGY TO LIMIT USAGE IN OPERATING ROOMS

8 CAPNOGRAPHY EQUIPMENT MARKET, BY APPLICATION

• 8.1 INTRODUCTION
• 8.2 CARDIAC CARE
  • 8.2.1 INCREASING NUMBER OF CARDIOPULMONARY SURGERIES AND RISING PREFERENCE FOR MONITORING ETCO2 LEVELS TO DRIVE MARKET
• 8.3 TRAUMA & EMERGENCY CARE
  • 8.3.1 INCREASING NUMBER OF ROAD ACCIDENTS TO SPUR MARKET GROWTH
• 8.4 RESPIRATORY MONITORING
  • 8.4.1 RISING PREVALENCE OF TARGET RESPIRATORY CONDITIONS TO SUPPORT MARKET GROWTH
• 8.5 OTHER APPLICATIONS

9 CAPNOGRAPHY EQUIPMENT MARKET, BY END USER

• 9.1 INTRODUCTION
• 9.2 HOSPITALS
  • 9.2.1 FOCUS ON REDUCING AIRWAY-RELATED DEATHS IN ICU PATIENTS TO ACCELERATE MARKET GROWTH
• 9.3 AMBULATORY SURGERY CENTERS & HOME CARE SETTINGS
  • 9.3.1 INCREASING NUMBER OF REIMBURSEMENT-APPROVED MEDICAL PROCEDURES UNDER ASC PAYMENT SYSTEM TO DRIVE MARKET
• 9.4 OTHER END USERS

10 CAPNOGRAPHY EQUIPMENT MARKET, BY REGION

• 10.1 INTRODUCTION
• 10.2 NORTH AMERICA
  • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 10.2.2 US
    • 10.2.2.1 US to dominate North American capnography equipment market during forecast period
  • 10.2.3 CANADA
    • 10.2.3.1 Rising prevalence of target respiratory diseases to support market growth
• 10.3 EUROPE
  • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 10.3.2 GERMANY
    • 10.3.2.1 Developed healthcare infrastructure and high government investments to spur market growth
  • 10.3.3 UK
    • 10.3.3.1 Increasing target patient population and rising healthcare expenditure to propel market growth
  • 10.3.4 FRANCE
    • 10.3.4.1 Growing awareness of capnography monitoring procedures and increasing number of trauma cases to augment market growth
  • 10.3.5 ITALY
    • 10.3.5.1 Rise in diabetes cases and high geriatric population to boost market growth
  • 10.3.6 SPAIN
    • 10.3.6.1 Increasing prevalence of lifestyle diseases to drive demand for capnography equipment
  • 10.3.7 REST OF EUROPE
• 10.4 ASIA PACIFIC
  • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 10.4.2 JAPAN
    • 10.4.2.1 Rising geriatric population and growing prevalence of obesity to augment market growth
  • 10.4.3 CHINA
    • 10.4.3.1 High target patient population and improved inpatient service availability to support market growth
  • 10.4.4 INDIA
    • 10.4.4.1 Favorable regulatory policies and high public healthcare expenditure to aid market growth
  • 10.4.5 AUSTRALIA
    • 10.4.5.1 Growing patient population and rising availability of grants to fuel market growth
  • 10.4.6 SOUTH KOREA
    • 10.4.6.1 Increased focus on R&D activities and high penetration of health insurance to propel market growth
  • 10.4.7 REST OF ASIA PACIFIC
• 10.5 LATIN AMERICA
  • 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 10.5.2 BRAZIL
    • 10.5.2.1 Improved healthcare sector and increased private-public investments to drive market
  • 10.5.3 MEXICO
    • 10.5.3.1 Favorable trade environment and easy entry of foreign players to fuel market growth
  • 10.5.4 REST OF LATIN AMERICA
• 10.6 MIDDLE EAST & AFRICA
  • 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 10.6.2 GCC COUNTRIES
    • 10.6.2.1 Healthcare infrastructural developments and increased focus on patient safety to drive market
  • 10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

• 11.1 INTRODUCTION
• 11.2 KEY PLAYER STRATEGY/RIGHT TO WIN
  • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN CAPNOGRAPHY EQUIPMENT MARKET
• 11.3 REVENUE ANALYSIS, 2019-2023
• 11.4 MARKET SHARE ANALYSIS, 2023
  • 11.4.1 RANKING OF KEY MARKET PLAYERS
• 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 11.5.1 STARS
  • 11.5.2 EMERGING LEADERS
  • 11.5.3 PERVASIVE PLAYERS
  • 11.5.4 PARTICIPANTS
  • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 11.5.5.1 Company footprint
    • 11.5.5.2 Product footprint
    • 11.5.5.3 Technology footprint
    • 11.5.5.4 Application footprint
    • 11.5.5.5 End-user footprint
    • 11.5.5.6 Region footprint
• 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 11.6.1 PROGRESSIVE COMPANIES
  • 11.6.2 RESPONSIVE COMPANIES
  • 11.6.3 DYNAMIC COMPANIES
  • 11.6.4 STARTING BLOCKS
  • 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
• 11.7 COMPANY VALUATION & FINANCIAL METRICS
  • 11.7.1 FINANCIAL METRICS
  • 11.7.2 COMPANY VALUATION
• 11.8 BRAND/PRODUCT COMPARISON
• 11.9 COMPETITIVE SCENARIO
  • 11.9.1 PRODUCT LAUNCHES AND APPROVALS
  • 11.9.2 DEALS

12 COMPANY PROFILES

• 12.1 KEY PLAYERS
  • 12.1.1 BECTON, DICKINSON AND COMPANY
    • 12.1.1.1 Business overview
    • 12.1.1.2 Products/Services/Solutions offered
    • 12.1.1.3 MnM view
      • 12.1.1.3.1 Right to win
      • 12.1.1.3.2 Strategic choices
      • 12.1.1.3.3 Weaknesses and competitive threats
  • 12.1.2 MEDTRONIC
    • 12.1.2.1 Business overview
    • 12.1.2.2 Products/Services/Solutions offered
    • 12.1.2.3 Recent developments
      • 12.1.2.3.1 Product approvals
      • 12.1.2.3.2 Deals
    • 12.1.2.4 MnM view
      • 12.1.2.4.1 Right to win
      • 12.1.2.4.2 Strategic choices
      • 12.1.2.4.3 Weaknesses and competitive threats
  • 12.1.3 KONINKLIJKE PHILIPS N.V.
    • 12.1.3.1 Business overview
    • 12.1.3.2 Products/Services/Solutions offered
    • 12.1.3.3 Recent developments
      • 12.1.3.3.1 Deals
    • 12.1.3.4 MnM view
      • 12.1.3.4.1 Right to win
      • 12.1.3.4.2 Strategic choices
      • 12.1.3.4.3 Weaknesses and competitive threats
  • 12.1.4 GE HEALTHCARE
    • 12.1.4.1 Business overview
    • 12.1.4.2 Products/Services/Solutions offered
    • 12.1.4.3 Recent developments
      • 12.1.4.3.1 Deals
    • 12.1.4.4 MnM view
      • 12.1.4.4.1 Right to win
      • 12.1.4.4.2 Strategic choices
      • 12.1.4.4.3 Weaknesses and competitive threats
  • 12.1.5 DRAGERWERK AG & CO. KGAA
    • 12.1.5.1 Business overview
    • 12.1.5.2 Products/Services/Solutions offered
    • 12.1.5.3 MnM view
      • 12.1.5.3.1 Right to win
      • 12.1.5.3.2 Strategic choices
      • 12.1.5.3.3 Weaknesses and competitive threats
  • 12.1.6 NIHON KOHDEN CORPORATION
    • 12.1.6.1 Business overview
    • 12.1.6.2 Products/Services/Solutions offered
    • 12.1.6.3 Recent developments
      • 12.1.6.3.1 Deals
  • 12.1.7 ZOLL MEDICAL CORPORATION
    • 12.1.7.1 Business overview
    • 12.1.7.2 Products/Services/Solutions offered
    • 12.1.7.3 Recent developments
      • 12.1.7.3.1 Deals
  • 12.1.8 EDAN INSTRUMENTS, INC.
    • 12.1.8.1 Business overview
    • 12.1.8.2 Products/Services/Solutions offered
  • 12.1.9 HAMILTON MEDICAL
    • 12.1.9.1 Business overview
    • 12.1.9.2 Products/Services/Solutions offered
    • 12.1.9.3 Recent developments
      • 12.1.9.3.1 Product launches
  • 12.1.10 MASIMO
    • 12.1.10.1 Business overview
    • 12.1.10.2 Products/Services/Solutions offered
    • 12.1.10.3 Recent developments
      • 12.1.10.3.1 Product approvals
  • 12.1.11 MINDRAY
    • 12.1.11.1 Business overview
    • 12.1.11.2 Products/Services/Solutions offered
    • 12.1.11.3 Recent developments
      • 12.1.11.3.1 Product launches
      • 12.1.11.3.2 Deals
  • 12.1.12 NONIN
    • 12.1.12.1 Business overview
    • 12.1.12.2 Products/Services/Solutions offered
    • 12.1.12.3 Recent developments
      • 12.1.12.3.1 Product launches
      • 12.1.12.3.2 Deals
  • 12.1.13 SCHILLER
    • 12.1.13.1 Business overview
    • 12.1.13.2 Products/Services/Solutions offered
  • 12.1.14 AVANTE
    • 12.1.14.1 Business overview
    • 12.1.14.2 Products/Services/Solutions offered
  • 12.1.15 ICU MEDICAL, INC.
    • 12.1.15.1 Business overview
    • 12.1.15.2 Products/Services/Solutions offered
    • 12.1.15.3 Recent developments
      • 12.1.15.3.1 Deals
• 12.2 OTHER PLAYERS
  • 12.2.1 BIONICS CO., LTD.
  • 12.2.2 BPL MEDICAL TECHNOLOGIES
  • 12.2.3 BURTONS MEDICAL EQUIPMENT, LTD.
  • 12.2.4 CRITICARE TECHNOLOGIES, INC.
  • 12.2.5 DIAMEDICA (UK) LIMITED
  • 12.2.6 INFINIUM MEDICAL
  • 12.2.7 SPACELABS HEALTHCARE
  • 12.2.8 NIDEK MEDICAL INDIA
  • 12.2.9 RESMED
  • 12.2.10 RECORDERS & MEDICARE SYSTEMS PVT. LTD.
  • 12.2.11 SHENZHEN COMEN MEDICAL INSTRUMENTS CO., LTD.
  • 12.2.12 SLE LTD.
  • 12.2.13 ZOE MEDICAL
  • 12.2.14 EMCO MEDITEK PVT. LTD.
  • 12.2.15 MONARCH MEDITECH

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 CUSTOMIZATION OPTIONS
• 13.4 RELATED REPORTS
• 13.5 AUTHOR DETAILS